title: BAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis.
authors.affiliation: Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Center Tower Room 404, Baltimore, MD, 21224, USA. cbingha2@jhmi.edu.
authors.forename: Clifton O
authors.initials: CO
authors.lastname: Bingham
authors.affiliation: Divisions of Infectious Diseases, Public Health, and Preventive Medicine, Oregon Health & Science University, 3375 SW Terwilliger Blvd, Portland, OR, 97239, USA.
authors.forename: Kevin L
authors.initials: KL
authors.lastname: Winthrop
authors.affiliation: Eli Lilly and Company, Indianapolis, IN, 46285, USA.
authors.forename: Lili
authors.initials: L
authors.lastname: Yang
authors.affiliation: Eli Lilly and Company, Indianapolis, IN, 46285, USA.
authors.forename: Chin
authors.initials: C
authors.lastname: Lee
authors.affiliation: Eli Lilly and Company, Indianapolis, IN, 46285, USA.
authors.forename: Wendy J
authors.initials: WJ
authors.lastname: Komocsar
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage / Q000276:immunology; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use; D018655:Lymphocyte Count; D008297:Male; D008727:Methotrexate / Q000276:immunology / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; C575974:tabalumab; D008727:Methotrexate